1134 – Hospitalisations for major adverse cardiovascular events in patients with diabetes from 1989 to 2015 in the north of Portugal – C. Neves, J. Neves, F. Lopes, S. Castro Oliveira, M. Pereira, A. Oliveira, D. Carvalho, Portugal

1135 – The maximum glucose peak during an oral glucose tolerance test is associated with greater arterial stiffness: the Maastricht Study – Y.D. Foreman, M.C. Brouwers, S.J. Eussen, M.M. Van Greevenbroek, R.M. Henry, C.J. Van der Kallen, K.D. Reesink, M.T. Schram, N.C. Schaper, C.D. Stehouwer, Netherlands

1136 – Quantitave myocardial blush evaluation correlates with infarct size and systolic left ventricle function in patients with type 2 diabetes and STEMI – J. Gumprecht, K. Nabrdalik, H. Kwiendacz, E. Radzik, K. Pigoń, M. Basiak, E. Nowalany-Kozielska, A. Tomasik, Poland

1137 – Differences in external validity of SGLT2-i cardiovascular outcome trials in general type 2 diabetes populations: a large observational study in European countries – K.I. Birkeland, J. Bodegard, A. Norhammar, J.G. Kuiper, W. Beekman-Hendriks, M. Thuresson, A. Kooy, Norway, Sweden, Netherlands

1138 – The REMOVAL trial: metformin reduces progression of mean carotid intima-media thickness (cIMT) in never smokers with type 1 diabetes – J.R. Petrie, N. Chaturvedi, I. Ford, M.C. Brouwers, N. Greenlaw, I. Hramiak, A.D. Hughes, A.J. Jenkins, B.E. Klein, R. Klein, P. Rossing, C.D. Stehouwer, N. Sattar, H.M. Colhoun, for the REMOVAL Study Group, UK, Netherlands, Canada, Australia, USA, Denmark

1139 – Effects of liraglutide on cardiovascular events in patients with type 2 diabetes and polyvascular disease: results of the LEADER trial – B. Zinman, S. Verma, D.L. Bhatt, S.C. Bain, J. Mann, M.A. Nauck, R.E. Pratley, M.M. Michelsen, T. Monk Fries, S. Rasmussen, L.A. Leiter, LEADER Publication Committee on behalf of the LEADER Trial Investigators, Canada, USA, UK, Germany, Denmark

1140 – Effect of 12 weeks continuous positive airway pressure on day and night arterial stiffness in patients with type 2 diabetes and obstructive sleep apnoea, a randomised trial – C. Krogager, A. Banghøj, P.L. Poulsen, M.G. Kirkegaard, L. Tarnow, K.W. Hansen, E. Laugesen, Denmark

1141 – Association between allopurinol and cardiovascular events and all-cause mortality in diabetes: a population-based cohort study – A. Weisman, G.A. Tomlinson, L. Lipscombe, B.A. Perkins, G.A. Hawker, Canada